Company-level financial information
CARDINAL HEALTH INC
Selected annual earnings and cash-flow facts from SEC filings. Each row identifies its exact reporting period and original filing.
Annual net income
| Reporting period | Measure | USD millions | Filing |
|---|---|---|---|
| Jun 30, 2026From Jul 1, 2025 | Operating cash flow | 5,174.0 | SEC filingAug 11, 2026 |
| Jun 30, 2026From Jul 1, 2025 | Net income | 1,714.0 | SEC filingAug 11, 2026 |
| Jun 30, 2026From Jul 1, 2025 | Common-stock cash dividends | 491.0 | SEC filingAug 11, 2026 |
| Jun 30, 2026From Jul 1, 2025 | Capital expenditures (PP&E) | 649.0 | SEC filingAug 11, 2026 |
| Jun 30, 2025From Jul 1, 2024 | Operating cash flow | 2,397.0 | SEC filingAug 11, 2026 |
| Jun 30, 2025From Jul 1, 2024 | Net income | 1,561.0 | SEC filingAug 11, 2026 |
| Jun 30, 2025From Jul 1, 2024 | Common-stock cash dividends | 494.0 | SEC filingAug 11, 2026 |
| Jun 30, 2025From Jul 1, 2024 | Capital expenditures (PP&E) | 547.0 | SEC filingAug 11, 2026 |
| Jun 30, 2024From Jul 1, 2023 | Operating cash flow | 3,762.0 | SEC filingAug 11, 2026 |
| Jun 30, 2024From Jul 1, 2023 | Net income | 852.0 | SEC filingAug 11, 2026 |
| Jun 30, 2024From Jul 1, 2023 | Common-stock cash dividends | 499.0 | SEC filingAug 11, 2026 |
| Jun 30, 2024From Jul 1, 2023 | Capital expenditures (PP&E) | 511.0 | SEC filingAug 11, 2026 |
| Jun 30, 2023From Jul 1, 2022 | Operating cash flow | 2,844.0 | SEC filingAug 12, 2025 |
| Jun 30, 2023From Jul 1, 2022 | Net income | 330.0 | SEC filingAug 12, 2025 |
| Jun 30, 2023From Jul 1, 2022 | Common-stock cash dividends | 525.0 | SEC filingAug 12, 2025 |
| Jun 30, 2023From Jul 1, 2022 | Capital expenditures (PP&E) | 481.0 | SEC filingAug 12, 2025 |
| Jun 30, 2022From Jul 1, 2021 | Operating cash flow | 3,175.0 | SEC filingAug 14, 2024 |
| Jun 30, 2022From Jul 1, 2021 | Net income | -938.0 | SEC filingAug 14, 2024 |
| Jun 30, 2022From Jul 1, 2021 | Common-stock cash dividends | 559.0 | SEC filingAug 14, 2024 |
| Jun 30, 2022From Jul 1, 2021 | Capital expenditures (PP&E) | 387.0 | SEC filingAug 14, 2024 |
| Jun 30, 2021From Jul 1, 2020 | Operating cash flow | 2,429.0 | SEC filingAug 15, 2023 |
| Jun 30, 2021From Jul 1, 2020 | Net income | 611.0 | SEC filingAug 15, 2023 |
| Jun 30, 2021From Jul 1, 2020 | Common-stock cash dividends | 573.0 | SEC filingAug 15, 2023 |
| Jun 30, 2021From Jul 1, 2020 | Capital expenditures (PP&E) | 400.0 | SEC filingAug 15, 2023 |
| Jun 30, 2020From Jul 1, 2019 | Operating cash flow | 1,960.0 | SEC filingAug 11, 2022 |
| Jun 30, 2020From Jul 1, 2019 | Net income | -3,696.0 | SEC filingAug 11, 2022 |
| Jun 30, 2020From Jul 1, 2019 | Common-stock cash dividends | 569.0 | SEC filingAug 11, 2022 |
| Jun 30, 2020From Jul 1, 2019 | Capital expenditures (PP&E) | 375.0 | SEC filingAug 11, 2022 |